3: Initial statement of beneficial ownership of securities-Officer JONES WILLIAM A JR
May 4 04:22
PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 30 05:06
424B3: Prospectus
Apr 20 04:25
EFFECT: Others
Apr 18 18:06
NewAmsterdam Pharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 13 04:20
NewAmsterdam Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Audet Juliette Berangere
Apr 3 04:37
NewAmsterdam Pharma | 8-K: Current report
Apr 1 20:21
NewAmsterdam Pharma | 4: Statement of changes in beneficial ownership of securities-Director Topper James N
Mar 29 04:36
NewAmsterdam Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kastelein Johannes Jacob Pieter
Mar 28 04:36
NewAmsterdam Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 27 05:40
NewAmsterdam Pharma | 424B3: Prospectus
Mar 13 04:26
NewAmsterdam Pharma | EFFECT: Others
Mar 11 18:06
NewAmsterdam Pharma | 8-K: Current report
Mar 4 21:10
NewAmsterdam Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BCLS Fund III Investments, LP(6.0%),BCLS II Investco, LP(5.4%), etc.
Mar 2 05:37
NewAmsterdam Pharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Feb 29 06:19
NewAmsterdam Pharma | 8-K: Current report
Feb 28 21:12
NewAmsterdam Pharma | 10-K: Annual report
Feb 28 21:02
NewAmsterdam Pharma | 4: Statement of changes in beneficial ownership of securities-Director LANGE LOUIS G
Feb 22 06:08
NewAmsterdam Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(14.2%),Patrick J. Heron(14.2%), etc.
Feb 22 00:15
NewAmsterdam Pharma | 8-K: Current report
Feb 16 05:25
No Data
No Data